Abstract:Pyrimidine-based heterocyclic compounds are garnering substantial interest due to their essential role as a class of natural and synthetic molecules. These compounds show a diverse array of biologically relevant activities, making them highly prospective candidates for clinical translation as therapeutic agents in combating various diseases. Pyrimidine derivatives and their fused analogues, such as thienopyrimidines, pyrazolopyrimidines, pyridopyrimidines, and pyrimidopyrimidines, hold immense possibility in both anticancer and antibacterial research. These compounds exhibit notable efficacy by targeting protein kinases, which are crucial enzymes regulating fundamental cellular processes like metabolism, migration, division, and growth. Through enzyme inhibition, these derivatives disrupt key cellular signaling pathways, thereby affecting critical cellular functions and viability. The advantage lies in the ubiquity of the pyrimidine structure across various natural compounds, enabling interactions with enzymes, genetic material, and cellular components pivotal for chemical and biological processes. This interaction plays a central role in modulating vital biological activities, making pyrimidine-containing compounds indispensable in drug discovery. In the realm of anticancer therapy, these compounds strategically target key proteins like EGFR, important for aberrant cell growth. Fused pyrimidine motifs, exemplified by various drugs, are designed to inhibit EGFR, thereby impeding tumor progression. Moreover, these compounds influence potent antibacterial activity, interfering with microbial growth through mechanisms ranging from DNA replication inhibition to other vital cellular functions. This dual activity, targeting both cancer cells and microbial pathogens, underscores the versatility and potential of pyrimidine derivatives in medical applications. This review provides insights into the structural characteristics, synthesis methods, and significant medicinal applications of fused pyrimidine derivatives, highlighting their double role in combating cancer and bacterial infections.

Pyrimidine-fused Dinitrogenous Penta-heterocycles As a Privileged Scaffold for Anti-Cancer Drug Discovery

Synthetic Strategies to Glycosylated Nitrogen-Containing Heterocyclic Compounds with Potential Anticancer Activities

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application

Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Application and SARs of Pyrazolo[1,5-a]pyrimidine As Antitumor Agents Scaffold.

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Recent Advances in the Development of Pyrazolopyridines As Anticancer Agents

Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates

Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential

Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery

Structural Activity Relationship-based Medicinal perceptions of Pyrazoline derivatives as Anti-Cancer Agents: A Review

Medicinal attributes of pyridine scaffold as anticancer targeting agents

Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)

Pyrimidine: An elite heterocyclic leitmotif in drug discovery‐synthesis and biological activity

The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids

Novel Fused Pyran Derivatives Induce Apoptosis and Target Cell Cycle Progression in Anticancer Efficacy against Multiple Cell Lines

Nitrogen-containing Fused Heterocycles: Organic Synthesis and Applications as Potential Anticancer Agents

Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential

Synthesis of Antitumor 3,4,6,7-Tetrahydro-2h-pyrimido[1,6-c]quinazolin-2-imine Derivatives Via Reductive Dearomatization-Initiated Intramolecular Cyclization